NCT04008797 2026-03-24
A Study of E7386 in Combination With Other Anticancer Drug(s) in Participants With Solid Tumor
Eisai Inc.
Phase 1/2 Active not recruiting
Clinical Trials
5 trialsNCT06084884 2026-03-09
ATHENA
AstraZeneca
Phase 1/2 Active not recruiting
NCT05438420 2026-02-24
Oral Axl/Mer/CSF1R Selective Tyrosine Kinase Inhibitor Q702 in Combination With Pembrolizumab in Patients With Selected Advanced Solid Tumors
Qurient Co., Ltd.
Phase 1/2 Active not recruiting
NCT07034950 2025-09-11
Effective Dose and Safety of Esketamine During Ultrasound-guided Hepatic Tumor Thermal Ablation
The First Affiliated Hospital of Xiamen University
Phase 1/2 Active not recruiting
NCT05964361 2025-04-25
IL15-TransDC
University Hospital, Antwerp
Phase 1/2 Active not recruiting